CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole
Authors
D. A. Cameron
Y. Chavarri-Guerra
+12Â more
N. E. Davidson
P. E. Goss
J. N. Ingle
R. B. Livingston
S. Martino
H. B. Muss
E. A. Perez
K. I. Pritchard
N. J. Robert
L. E. Shepherd
D. Tu
T. Whelan
Publication date
1 October 2012
Publisher
Doi
Cite
View
on
PubMed
Abstract
MA17 showed improved outcomes in postmenopausal women given extended letrozole (LET) after completing 5 years of adjuvant tamoxifen
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Carolina Digital Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
cdr.lib.unc.edu:7w62ff944
Last time updated on 24/11/2020
